Am J Physiol Cell Physiol Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Cell Physiol (June 17, 2009). doi:10.1152/ajpcell.00135.2009
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
297/3/C601    most recent
00135.2009v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Wong, T. P.
Right arrow Articles by Leung, P. S.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wong, T. P.
Right arrow Articles by Leung, P. S.
Submitted on March 25, 2009
Revised on May 22, 2009
Accepted on June 15, 2009

Diabetes mellitus and expression of the enterocyte renin-angiotensin system: implications for control of glucose transport across the brush border membrane

Tung Po Wong1, Edward S Debnam2, and Po Sing Leung1*

1 The Chinese University of Hong Kong
2 University College London

* To whom correspondence should be addressed. E-mail: psleung{at}cuhk.edu.hk.

Streptozotocin-induced (Type 1) diabetes mellitus (T1DM) in rats promotes jejunal glucose transport but the trigger for this response remains unclear. Our recent work using euglycemic rats has implicated the enterocyte renin-angiotensin system (RAS) in control of SGLT1-mediated glucose uptake across the jejunal brush border membrane (BBM). The aim of present study was to examine whether expression of enterocyte RAS components are influenced by T1DM. The effects of mucosal addition of angiotensin II (AII) on [14C]-D-glucose uptake by everted diabetic jejunum was also determined. Two-week diabetes caused a 5-fold increase in blood glucose level and reduced mRNA and protein expression of AT1- and AT2-receptors and ACE in isolated jejunal enterocytes. Angiotensinogen expression was however stimulated by diabetes whilst renin was not detected in either control or diabetic enterocytes. Diabetes stimulated glucose uptake into everted jejunum by 58% and increased the BBM expression of SGLT1 and GLUT2 proteins, determined by Western blotting by 25% and 135%, respectively. Immunohistochemistry confirmed an enhanced BBM expression of GLUT2 in diabetes and also showed that this was due to translocation of the transporter from the basolateral membrane (BLM) to BBM. AII (5µM) or L-162313 (1µM), a non-peptide AII analogue decreased glucose uptake by 18% and 24%, respectively in diabetic jejunum. This inhibitory action was fully accountable by an action on SGLT1-mediated transport and was abolished by the AT1-receptor antagonist losartan (1 µM). The decreased inhibitory action of AII on in vitro jejunal glucose uptake in diabetes compared to that noted previously in jejunum from normal animals is likely to be due to reduced RAS expression in diabetic enterocytes, together with a disproportionate increase in GLUT2, compared to SGLT1 expression at the BBM.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.